Managed by NetworkPharma

Managed by
NetworkPharma

The Publication Plan

WHAT'S THIS?

  • Home
  • About us
  • Email sign up
  • Basics
  • Features
  • Commentary

    - General
    - Best practice
    - Clinical trial registries
    - Selective publication
    - Industry payments
    - Authorship

  • Viewpoints
  • Advertorials
  • Press releases
  • Resources
  • Events
  • Directory
  • Webcasts

  • Join The Publication Plan LinkedIn Group
    Join The Publication Plan LinkedIn Group here.



    This is a freely accessible online resource for everyone involved in publication planning. Help us build the site into a valuable resource for, amongst others, medical writers and communications professionals, pharmaceutical industry managers, medical journal editors and publishers.

    If you have any contributions, ideas, comments about the service or questions about advertising and sponsorship, please contact the Publisher, Peter Llewellyn.

    Managed by NetworkPharma

    Managed by
    NetworkPharma


    Related Sites

    European CME Forum

    KeywordPharma

    MedComms Networking

    ThePharmYard

    COMMENTARY

    This section collates links to previously published articles and news stories.

    The five latest additions are highlighted below, the rest can be found via the menu on the left.


    Time for fair trade in research data
    Published 27 February 2010

    Elizabeth Pisani and colleagues write in The Lancet about how Geneticists, astrophysicists, and molecular biologists routinely share research data with colleagues and rivals alike. The reason is that scientists and their funders know we will understand complex issues sooner if people build on one another's work. Yet scientists in the complex area of public health have been left behind in the data-sharing revolution.

    [Link to original source material]


    Serving Two Masters — Conflicts of Interest in Academic Medicine
    Published 25 February 2010

    Bernard Lo argues in the NEJM, that the public grants the medical profession considerable discretion in setting its own standards because it trusts that physicians will place patients' interests ahead of their own or those of third parties. To maintain this trust, academic health centers should take the lead in addressing conflicts of interest in medicine, rather than merely responding to government requirements and adverse publicity about troubling cases.

    [Link to original source material]


    Publishing information about ongoing clinical trials for patients
    Published 24 February 2010

    It is often difficult for patients who want to take part in clinical trials to find the required information. In an Analysis article in the BMJ, Fiona Godlee and Iain Chalmers argue that their needs can and should be met.

    [Link to original source material]


    Registering Clinical Trial Results: The Next Step
    Published 24 February 2010

    An Commentary in JAMA says the NIH, in developing its provisions and policies governing registration of the results of drug clinical trials on ClinicalTrials.gov, should focus on promoting improvements in the quality and reliability of clinical research on drugs. These improvements can occur only by increasing transparency and reproducibility. Mandatory registration of the protocols for drug clinical trials, as well as posting all patient-level data collected in those trials, are essential for clinical research on drugs to move to the next step.

    [Link to original source material]


    Registration of observational studies
    Published 18 February 2010

    An Editorial in the BMJ says registration of observational studies is just one of many changes needed to increase confidence in observational research, but they believe it is the crucial next step. The aim would be to facilitate the design and reporting of observational research, not to hinder it. Trial registration has had a substantial and important positive effect on the design, conduct, and reporting of randomised clinical trials, and the BMJ believes it is time to extend those benefits to observational research.

    [Link to original source material]

    WHAT ELSE?

    NEWS ALERT!

    Do you want to be alerted to important news and events relevant to publication planning?

    Sign up here.


    Complimentary publications workshop, 30 March 2010, Hilton Hotel, Aeschengraben 31, 4051 Basel, Switzerland, Organized by Elsevier

    COMPLIMENTARY PUBLICATIONS WORKSHOP FOR INDUSTRY

    30 March 2010
    Hilton Hotel, Aeschengraben 31, 4051 Basel, Switzerland
    Organized by Elsevier

    Attendance at this session is FREE.
    Pre-registration is compulsory.

    More information here.


    6th Annual Meeting of ISMPP, Delivering Value & Driving Advocacy in Medical Publication Planning, 19-21 April 2010, Arlington, Virginia

    6th Annual Meeting of ISMPP, Delivering Value & Driving Advocacy in Medical Publication Planning

    19-21 April 2010
    Arlington, Virginia

    More information here.


    TIPPA’s 8th Annual Meeting: Rising to the Challenge: Bridging the gap between industry, academia and the general public, June 24th - 25th, 2010, The Marines’ Memorial Club, San Francisco, CA

    This web site and associated activities are being managed by NetworkPharma Ltd, 89 Oxford Road, Oxford, OX2 9PD, UK
    Telephone +44 (0) 1865 865943 Email: support@networkpharma.com

    Other services managed by NetworkPharma
    [www.EuropeanCMEforum.eu] [www.KeywordPharma.com] [www.MedCommsNetworking.co.uk] [www.NetworkPharma.tv] [www.ThePharmYard.com]